SPMIP1
gene geneOn this page
Summary
SPMIP1 (sperm microtubule inner protein 1, HGNC:52392) is a protein-coding gene on chromosome 7q32.1, encoding Protein SPMIP1 (A0A1B0GUX0).
At a glance
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_001195150
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:52392 |
| Approved symbol | SPMIP1 |
| Name | sperm microtubule inner protein 1 |
| Location | 7q32.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000272899 |
| Ensembl biotype | protein_coding |
| Entrez | 100130705 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000609480
RefSeq mRNA: 1 — MANE Select: NM_001195150
NM_001195150
CCDS: CCDS83222
Canonical transcript exons
ENST00000609480 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001890050 | 128866330 | 128866830 |
| ENSE00003703672 | 128868666 | 128872047 |
Expression profiles
Bgee: expression breadth ubiquitous, 166 present calls, max score 86.51.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0653 / max 65.4073, expressed in 5 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 80990 | 0.0421 | 4 |
| 80989 | 0.0232 | 4 |
Top tissues by expression
248 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right hemisphere of cerebellum | UBERON:0014890 | 86.51 | gold quality |
| tibialis anterior | UBERON:0001385 | 85.67 | silver quality |
| cerebellar hemisphere | UBERON:0002245 | 85.29 | gold quality |
| cerebellar cortex | UBERON:0002129 | 85.08 | gold quality |
| cerebellum | UBERON:0002037 | 82.66 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 82.39 | gold quality |
| metanephros cortex | UBERON:0010533 | 80.53 | gold quality |
| gastrocnemius | UBERON:0001388 | 77.50 | gold quality |
| endothelial cell | CL:0000115 | 75.17 | gold quality |
| muscle of leg | UBERON:0001383 | 74.36 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 73.72 | gold quality |
| cortical plate | UBERON:0005343 | 72.72 | gold quality |
| right frontal lobe | UBERON:0002810 | 72.71 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 72.23 | gold quality |
| prefrontal cortex | UBERON:0000451 | 71.99 | gold quality |
| amygdala | UBERON:0001876 | 71.30 | gold quality |
| neocortex | UBERON:0001950 | 70.88 | gold quality |
| frontal cortex | UBERON:0001870 | 70.74 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 70.69 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 69.81 | gold quality |
| cerebral cortex | UBERON:0000956 | 69.51 | gold quality |
| temporal lobe | UBERON:0001871 | 68.78 | gold quality |
| metanephros | UBERON:0000081 | 67.95 | gold quality |
| primary visual cortex | UBERON:0002436 | 67.53 | gold quality |
| cortex of kidney | UBERON:0001225 | 67.49 | gold quality |
| postcentral gyrus | UBERON:0002581 | 67.35 | gold quality |
| deltoid | UBERON:0001476 | 66.73 | silver quality |
| superior frontal gyrus | UBERON:0002661 | 66.70 | gold quality |
| entorhinal cortex | UBERON:0002728 | 66.57 | gold quality |
| brain | UBERON:0000955 | 66.43 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.22 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
103 targeting SPMIP1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-32-5P | 99.98 | 75.21 | 1964 |
| HSA-MIR-92A-3P | 99.98 | 75.21 | 1960 |
| HSA-MIR-92B-3P | 99.98 | 75.25 | 1955 |
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
| HSA-MIR-363-3P | 99.98 | 74.72 | 1821 |
| HSA-MIR-367-3P | 99.98 | 74.83 | 1819 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
| HSA-MIR-944 | 99.82 | 70.85 | 3042 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-204-5P | 99.79 | 71.62 | 2439 |
| HSA-MIR-211-5P | 99.79 | 71.65 | 2440 |
| HSA-MIR-1273H-5P | 99.77 | 66.32 | 2471 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-11181-3P | 99.75 | 66.38 | 2205 |
| HSA-MIR-556-3P | 99.74 | 68.75 | 1203 |
| HSA-MIR-1255A | 99.74 | 68.09 | 744 |
| HSA-MIR-1255B-5P | 99.74 | 68.16 | 741 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-6779-5P | 99.70 | 65.76 | 2363 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spmip1 | ENSMUSG00000090685 |
| rattus_norvegicus | Spmip1 | ENSRNOG00000086561 |
Protein
Protein identifiers
Protein SPMIP1 — A0A1B0GUX0 (reviewed: A0A1B0GUX0)
Alternative names: ATP6V1F neighbor gene protein, Protein ATP6V1FNB, Sperm-associated microtubule inner protein 1
All UniProt accessions (1): A0A1B0GUX0
RefSeq proteins (1): NP_001182079* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR054323 | SPMIP1_C | Domain |
Pfam: PF22589
UniProt features (3 total): chain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A1B0GUX0-F1 | 79.65 | 0.36 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 22 (showing top):
chr7q32, DODD_NASOPHARYNGEAL_CARCINOMA_UP, LMTK3_TARGET_GENES, ZFHX3_TARGET_GENES, MIR8068, MIR4427, MIR5589_3P, MIR556_3P, BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP, BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP, BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP, BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP, GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_DN, GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN, GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
96 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPMIP1 | CCDC127 | Q96BQ5 | 640 |
| SPMIP1 | CST11 | Q9H112 | 624 |
| SPMIP1 | CFAP61 | Q8NHU2 | 623 |
| SPMIP1 | DEFB130A | P0DP74 | 598 |
| SPMIP1 | GCAT | O75600 | 593 |
| SPMIP1 | HOGA1 | Q86XE5 | 590 |
| SPMIP1 | C6orf58 | Q6P5S2 | 559 |
| SPMIP1 | FSIP2 | Q5CZC0 | 502 |
| SPMIP1 | DNAH8 | Q96JB1 | 474 |
| SPMIP1 | AKAP4 | Q5JQC9 | 389 |
| SPMIP1 | TEKT5 | Q96M29 | 387 |
| SPMIP1 | ODF4 | Q2M2E3 | 348 |
| SPMIP1 | CIMAP1A | Q96PU9 | 326 |
| SPMIP1 | UBB | P02248 | 300 |
| SPMIP1 | IZUMO1 | Q8IYV9 | 299 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1B0GTD5, A0A1B0GUX0, A0A3Q1MT14, A4D263, A6NL82, A6QQL5, A8QW39, B0UXH9, B5X5D0, B9EJX3, E1B9R1, F1MMV1, Q148A4, Q1JPL0, Q2T9T0, Q32KQ1, Q32L72, Q32L77, Q32P67, Q3V0J4, Q5BN46, Q5NC57, Q5NC83, Q5SPV6, Q5SS90, Q5SVJ3, Q5VTT2, Q5VZQ5, Q66HC0, Q66HR9, Q6AYM0, Q6NXP0, Q6P3G4, Q6ZVS7, Q80X60, Q8CDT5, Q8CDU5, Q8N5S3, Q8N7U6, Q8N865
Diamond homologs: A0A1B0GUX0, B9EJX3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
1118 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:128866821:T:A | W138R | 0.971 |
| 7:128866821:T:C | W138R | 0.971 |
| 7:128866494:T:A | W29R | 0.970 |
| 7:128866494:T:C | W29R | 0.970 |
| 7:128866734:G:A | G109R | 0.962 |
| 7:128866734:G:C | G109R | 0.962 |
| 7:128866823:G:C | W138C | 0.959 |
| 7:128866823:G:T | W138C | 0.959 |
| 7:128866759:G:C | R117P | 0.958 |
| 7:128866819:G:A | G137D | 0.951 |
| 7:128868719:T:C | F159L | 0.951 |
| 7:128868721:C:A | F159L | 0.951 |
| 7:128868721:C:G | F159L | 0.951 |
| 7:128866734:G:T | G109W | 0.946 |
| 7:128866746:T:G | Y113D | 0.946 |
| 7:128866735:G:A | G109E | 0.936 |
| 7:128866785:T:G | Y126D | 0.935 |
| 7:128866806:A:C | S133R | 0.934 |
| 7:128866808:C:A | S133R | 0.934 |
| 7:128866808:C:G | S133R | 0.934 |
| 7:128866750:T:C | L114P | 0.933 |
| 7:128866735:G:T | G109V | 0.932 |
| 7:128866738:G:C | R110P | 0.930 |
| 7:128866783:G:C | R125P | 0.929 |
| 7:128866747:A:C | Y113S | 0.920 |
| 7:128866822:G:C | W138S | 0.920 |
| 7:128866713:G:C | G102R | 0.914 |
| 7:128866746:T:C | Y113H | 0.905 |
| 7:128866496:G:C | W29C | 0.904 |
| 7:128866496:G:T | W29C | 0.904 |
dbSNP variants (sampled 300 via entrez): RS1000158557 (7:128867359 A>C), RS1000367261 (7:128870159 T>C,G), RS1001111000 (7:128869076 T>C), RS1001162110 (7:128866041 G>T), RS1001422788 (7:128871129 G>A,C), RS1002337649 (7:128870680 C>A,G), RS1003559243 (7:128866903 G>C), RS1003751117 (7:128871869 AATTT>A), RS1003846461 (7:128868229 G>A,C), RS1004328690 (7:128872341 T>A), RS1004611932 (7:128871046 G>A), RS1004622091 (7:128866677 C>G,T), RS1004664486 (7:128870771 G>A), RS1004853761 (7:128869432 C>A), RS1005491506 (7:128869205 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| 2-methyl-4-isothiazolin-3-one | increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| 2,3,5-trichloro-6-phenyl-(1,4)benzoquinone | decreases expression | 1 |
| Cadmium | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Acrylamide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.